These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

179 related articles for article (PubMed ID: 27387749)

  • 21. Phosphatidic Acid Improves Reprogramming to Pluripotency by Reducing Apoptosis.
    Jiang Y; Du M; Wu M; Zhu Y; Zhao X; Cao X; Li X; Long P; Li W; Hu B
    Stem Cells Dev; 2016 Jan; 25(1):43-54. PubMed ID: 26451619
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Induced pluripotent stem (iPS) cells: a new source for cell-based therapeutics?
    de Lázaro I; Yilmazer A; Kostarelos K
    J Control Release; 2014 Jul; 185():37-44. PubMed ID: 24746625
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Generation of mouse induced pluripotent stem cells from different genetic backgrounds using Sleeping beauty transposon mediated gene transfer.
    Muenthaisong S; Ujhelly O; Polgar Z; Varga E; Ivics Z; Pirity MK; Dinnyes A
    Exp Cell Res; 2012 Nov; 318(19):2482-9. PubMed ID: 22846649
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Induced Pluripotent Stem Cells: Generation, Characterization, and Differentiation--Methods and Protocols.
    Graversen VK; Chavala SH
    Methods Mol Biol; 2016; 1357():395-401. PubMed ID: 25403469
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Differentiation of reprogrammed mouse cardiac fibroblasts into functional cardiomyocytes.
    Jiang B; Dong H; Li Q; Yu Y; Zhang Z; Zhang Y; Wang G; Zhang Z
    Cell Biochem Biophys; 2013 Jun; 66(2):309-18. PubMed ID: 23212180
    [TBL] [Abstract][Full Text] [Related]  

  • 26. iPS Cells 10 Years Later.
    Cell; 2016 Sep; 166(6):1356-1359. PubMed ID: 27610558
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Production of Retinal Cells from Confluent Human iPS Cells.
    Reichman S; Goureau O
    Methods Mol Biol; 2016; 1357():339-51. PubMed ID: 25417064
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Induced pluripotent stem cells as a new strategy for cardiac regeneration and disease modeling.
    Iglesias-García O; Pelacho B; Prósper F
    J Mol Cell Cardiol; 2013 Sep; 62():43-50. PubMed ID: 23643470
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Induced pluripotent stem cells: opportunities as research and development tools in 21st century drug discovery.
    Rowntree RK; McNeish JD
    Regen Med; 2010 Jul; 5(4):557-68. PubMed ID: 20632859
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Prospects of induced pluripotent stem cell technology in regenerative medicine.
    Zhang F; Citra F; Wang DA
    Tissue Eng Part B Rev; 2011 Apr; 17(2):115-24. PubMed ID: 21210760
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Generation of induced pluripotent stem cells without Myc from mouse and human fibroblasts.
    Nakagawa M; Koyanagi M; Tanabe K; Takahashi K; Ichisaka T; Aoi T; Okita K; Mochiduki Y; Takizawa N; Yamanaka S
    Nat Biotechnol; 2008 Jan; 26(1):101-6. PubMed ID: 18059259
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Retroviral vector silencing during iPS cell induction: an epigenetic beacon that signals distinct pluripotent states.
    Hotta A; Ellis J
    J Cell Biochem; 2008 Nov; 105(4):940-8. PubMed ID: 18773452
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Non-viral methods for generating integration-free, induced pluripotent stem cells.
    Deng XY; Wang H; Wang T; Fang XT; Zou LL; Li ZY; Liu CB
    Curr Stem Cell Res Ther; 2015; 10(2):153-8. PubMed ID: 25248676
    [TBL] [Abstract][Full Text] [Related]  

  • 34. More synergetic cooperation of Yamanaka factors in induced pluripotent stem cells than in embryonic stem cells.
    Huang J; Chen T; Liu X; Jiang J; Li J; Li D; Liu XS; Li W; Kang J; Pei G
    Cell Res; 2009 Oct; 19(10):1127-38. PubMed ID: 19736564
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Cynomolgus Monkey Induced Pluripotent Stem Cells Generated By Using Allogeneic Genes.
    Shimozawa N
    Methods Mol Biol; 2016; 1357():173-82. PubMed ID: 25410287
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Enhancing Human Cardiomyocyte Differentiation from Induced Pluripotent Stem Cells with Trichostatin A.
    Lim SY; Sivakumaran P; Crombie DE; Dusting GJ; Pébay A; Dilley RJ
    Methods Mol Biol; 2016; 1357():415-21. PubMed ID: 25520285
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Emerging methods for preparing iPS cells.
    Miyazaki S; Yamamoto H; Miyoshi N; Takahashi H; Suzuki Y; Haraguchi N; Ishii H; Doki Y; Mori M
    Jpn J Clin Oncol; 2012 Sep; 42(9):773-9. PubMed ID: 22826352
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Pluripotent stem cells induced from mouse neural stem cells and small intestinal epithelial cells by small molecule compounds.
    Ye J; Ge J; Zhang X; Cheng L; Zhang Z; He S; Wang Y; Lin H; Yang W; Liu J; Zhao Y; Deng H
    Cell Res; 2016 Jan; 26(1):34-45. PubMed ID: 26704449
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Future perspective of induced pluripotent stem cells for diagnosis, drug screening and treatment of human diseases.
    Lian Q; Chow Y; Esteban MA; Pei D; Tse HF
    Thromb Haemost; 2010 Jul; 104(1):39-44. PubMed ID: 20539907
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Potentialities of induced pluripotent stem (iPS) cells for treatment of diseases.
    Chakraborty C; Shah KD; Cao WG; Hsu CH; Wen ZH; Lin CS
    Curr Mol Med; 2010 Nov; 10(8):756-62. PubMed ID: 20937020
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.